Stemmer Imaging AG (S9I.DE)
EUR 54.0
(0.0%)
EUR 54.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 20.13 Million | 15.89 Million | 7.96 Million | 10.88 Million | 1.85 Million | 4.93 Million |
| Net Income | 15.73 Million | 17.97 Million | 10.45 Million | -3.32 Million | -2.8 Million | 4.38 Million |
| Depreciation & Amortization | 5.09 Million | 3.9 Million | 3.93 Million | 9.36 Million | 5.05 Million | 1.45 Million |
| Deferred income taxes | -180 Thousand | -253 Thousand | -385 Thousand | -448 Thousand | -425 Thousand | - |
| Stock-based compensation | 135 Thousand | -117 Thousand | 235 Thousand | - | - | - |
| Change in working capital | 3.8 Million | -9.01 Million | -5.32 Million | 4.49 Million | 1.52 Million | -2.56 Million |
| Other non-cash items | 5.87 Million | 3.4 Million | -936 Thousand | 345 Thousand | 8.6 Million | 1.66 Million |
| Investing Cash Flow | -1.02 Million | -1.31 Million | 176 Thousand | -353 Thousand | -25.64 Million | -2.09 Million |
| Investments in PPE | -1.05 Million | -1.16 Million | -249 Thousand | -425 Thousand | -2 Million | -1.3 Million |
| Acquisitions | 28 Thousand | 33 Thousand | 10 Thousand | 37 Thousand | -23.64 Million | -4.47 Million |
| Investment purchases | -3000.00 | -180 Thousand | -19.58 Million | -13 Thousand | - | -1.4 Million |
| Sales/Maturities of investments | - | -33 Thousand | 19.88 Million | 12 Thousand | - | 5.07 Million |
| Other Investing Activities | 1.00 | 33 Thousand | 124 Thousand | 36 Thousand | 11 Thousand | 12 Thousand |
| Financing Cash Flow | -23.08 Million | -8.74 Million | -6.93 Million | -3.52 Million | 5.31 Million | -3.33 Million |
| Debt repayment | -3.88 Million | -3.87 Million | -3.8 Million | -3.97 Million | -8.53 Million | -55 Thousand |
| Dividends payments | -19.5 Million | -4.87 Million | -1.95 Million | - | -1.75 Million | -1.75 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 305 Thousand | 3000.00 | 118 Thousand | 457 Thousand | -1.46 Million | -1.52 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 10.02 Million | -10.92 Million | -6.9 Million | 1.65 Million | 2.12 Million | -1.31 Million |
| Other working capital | -6.21 Million | 1.91 Million | 1.57 Million | 2.84 Million | 1.52 Million | -1.25 Million |
| Cash at beginning of period | 41.57 Million | 36.02 Million | 34.71 Million | 27.97 Million | 46.73 Million | 46.73 Million |
| Cash at end of period | 37.57 Million | 41.57 Million | 36.02 Million | 34.71 Million | 27.97 Million | 46.25 Million |
| Capital Expenditure | -1.05 Million | -1.16 Million | -249 Thousand | -425 Thousand | -2 Million | -1.3 Million |
| Effect of forex changes on cash | -29 Thousand | -285 Thousand | 97 Thousand | -264 Thousand | 185 Thousand | 13 Thousand |
| Net cash flow / Change in cash | -4 Million | 5.55 Million | 1.3 Million | 6.74 Million | -18.75 Million | -473 Thousand |
| Free Cash Flow | 19.08 Million | 14.72 Million | 7.72 Million | 10.45 Million | -153 Thousand | 3.63 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.87 Million | 2.23 Million | 15.73 Million | 4.23 Million | 2.7 Million | 4.2 Million |
| Depreciation & Amortization | 903 Thousand | 970 Thousand | 5.09 Million | 1.2 Million | 1.86 Million | 971 Thousand |
| Deferred income taxes | - | - | -180 Thousand | -180 Thousand | - | - |
| Stock-based compensation | - | - | 135 Thousand | 135 Thousand | - | - |
| Change in working capital | 2.48 Million | 6.67 Million | 3.8 Million | -466 Thousand | 4.02 Million | 1.36 Million |
| Other non-cash items | 12 Thousand | 1.42 Million | 5.87 Million | 2.03 Million | -1.03 Million | -3.78 Million |
| Investing Cash Flow | -3.02 Million | -167 Thousand | -1.02 Million | -14 Thousand | -328 Thousand | -347 Thousand |
| Investments in PPE | -202 Thousand | -167 Thousand | -1.05 Million | -42 Thousand | -325 Thousand | -381 Thousand |
| Acquisitions | -2.82 Million | - | 28 Thousand | 28 Thousand | -36 Thousand | 34 Thousand |
| Investment purchases | - | - | -3000.00 | - | -3000.00 | - |
| Sales/Maturities of investments | - | - | - | - | 217 Thousand | - |
| Other Investing Activities | -181 Thousand | -144 Thousand | 1.00 | 8000.00 | -181 Thousand | -170 Thousand |
| Financing Cash Flow | -18.58 Million | -957 Thousand | -23.08 Million | -778 Thousand | -956 Thousand | -20.43 Million |
| Debt repayment | -991 Thousand | -962 Thousand | -3.88 Million | -948 Thousand | -955 Thousand | -995 Thousand |
| Dividends payments | -12.17 Million | - | -19.5 Million | -6.02 Million | - | -13.47 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 5000.00 | 5000.00 | 305 Thousand | 6.19 Million | -1000.00 | 58 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -894 Thousand | 5.96 Million | 10.02 Million | 3.91 Million | 5.6 Million | 2.26 Million |
| Other working capital | 2.46 Million | 6.67 Million | -6.21 Million | -4.38 Million | -1.58 Million | -898 Thousand |
| Cash at beginning of period | 45.72 Million | 37.57 Million | 41.57 Million | 33.9 Million | 27.65 Million | 45.69 Million |
| Cash at end of period | 30.26 Million | 45.72 Million | 37.57 Million | 37.57 Million | 33.9 Million | 27.65 Million |
| Capital Expenditure | -202 Thousand | -167 Thousand | -1.05 Million | -42 Thousand | -325 Thousand | -381 Thousand |
| Effect of forex changes on cash | 48 Thousand | -78 Thousand | -29 Thousand | 45 Thousand | -22 Thousand | -19 Thousand |
| Net cash flow / Change in cash | -15.46 Million | 8.15 Million | -4 Million | 3.66 Million | 6.25 Million | -18.04 Million |
| Free Cash Flow | 5.89 Million | 9.19 Million | 19.08 Million | 4.37 Million | 7.23 Million | 2.37 Million |
7294
3449
ATLCL
KNEBV
XEBEQ
ASN